| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1997;64:993-998
© 1997 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, Department of Surgery, and Divisions of Cardiology and Biomedical Research, Department of Medicine, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts
Background. Hypoxic endothelial cell activation plays a key role in the myocardial dysfunction resulting from ischemia-reperfusion injury. Recent evidence suggests that vascular endothelial growth factor (VEGF) may, in addition to promoting angiogenesis, modulate various aspects of endothelial function and repair. We examined whether administration of VEGF in the cardioplegic solution might have a beneficial effect on myocardial ischemia-reperfusion injury in an isolated rat heart model.
Methods. Hearts from Sprague-Dawley rats were perfused with Krebs-Henseleit solution in a modified Langendorff apparatus. Percent recovery of cardiac output, coronary flow, stroke work, and percent increase in coronary vascular resistance were measured after 2 hours of global ischemia and 40 minutes of reperfusion. Coronary effluent was collected after ischemia and reperfusion for measurement of creatine kinase.
Results. Hearts receiving cardioplegia solution containing 125 µg VEGF showed significantly improved recovery of cardiac output, coronary flow, and stroke work, and significantly reduced coronary vascular resistance compared with hearts receiving hyperkalemic cardioplegia only (p < 0.05). Coadministration of a nitric oxide synthase inhibitor attenuated the VEGF-induced cardiprotective effects. Hearts treated with VEGF released significantly less creatine kinase compared with control hearts.
Conclusions. Addition of VEGF to hyperkalemic cardioplegia protects against myocardial ischemia-reperfusion injury in the isolated rat heart.
This article has been cited by other articles:
|
|
 |
|
  J.-e. Obata, Y. Kitta, H. Takano, Y. Kodama, T. Nakamura, A. Mende, K.-i. Kawabata, Y. Saitoh, D. Fujioka, T. Kobayashi, et al. Sirolimus-Eluting Stent Implantation Aggravates Endothelial Vasomotor Dysfunction in the Infarct-Related Coronary Artery in Patients With Acute Myocardial Infarction J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1305 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Tsuchihashi, B. Ke, F. Kaldas, E. Flynn, R. W. Busuttil, D. M. Briscoe, and J. W. Kupiec-Weglinski Vascular Endothelial Growth Factor Antagonist Modulates Leukocyte Trafficking and Protects Mouse Livers against Ischemia/Reperfusion Injury Am. J. Pathol., February 1, 2006; 168(2): 695 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Matsumoto, T. Omura, M. Yoshiyama, T. Hayashi, S. Inamoto, K.-R. Koh, K. Ohta, Y. Izumi, Y. Nakamura, K. Akioka, et al. Vascular Endothelial Growth Factor-Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1168 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kofidis, J. L. de Bruin, T. Yamane, M. Tanaka, D. R. Lebl, R.-J. Swijnenburg, I. L. Weissman, and R. C. Robbins Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury Circulation, May 17, 2005; 111(19): 2486 - 2493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schulz, M. Kelm, and G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 402 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Hausenloy and D. M Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res, February 15, 2004; 61(3): 448 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. Cotton, A. Mathur, Y. Hong, A.S. Brown, J.F. Martin, and J.D. Erusalimsky Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery Eur. Heart J., June 2, 2002; 23(12): 953 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Suzuki, B. Murtuza, R. T. Smolenski, I. A. Sammut, N. Suzuki, Y. Kaneda, and M. H. Yacoub Cell Transplantation for the Treatment of Acute Myocardial Infarction Using Vascular Endothelial Growth Factor-Expressing Skeletal Myoblasts Circulation, September 18, 2001; 104(90001): I-207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.J. Chambers Vascular endothelial growth factor and coronary artery surgery: implications for improved endothelial protection! Eur. Heart J., October 2, 2000; 21(20): 1649 - 1651. [PDF]
|
|
|
|
|
|
P.B.J Burton, V.J Owen, S Hafizi, P.J.R Barton, G Carr-White, T Koh, A De Souza, M.H Yacoub, and J.R Pepper Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery Eur. Heart J., October 2, 2000; 21(20): 1708 - 1713. [Abstract] [PDF]
|
|
|
|
|
|
D. Mukherjee, J. Wong, B. Griffin, S. G. Ellis, T. Porter, S. Sen, and J. D. Thomas Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1678 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-s. Cheng, R. M. Rodriguez, E. A. Perkett, J. Rogers, G. Bienvenu, U. Lappalainen, and R. W. Light Vascular Endothelial Growth Factor in Pleural Fluid Chest, September 1, 1999; 116(3): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. SCALIA, G. BOOTH, and D. J. LEFER Vascular endothelial growth factor attenuates leukocyte–endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide FASEB J, June 1, 1999; 13(9): 1039 - 1046. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Basile-Borgia, J. H Abel, and H. Mahloogi Molecular advances in cardiac and cardiovascular disease Perfusion, March 1, 1999; 14(2): 89 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Kawata, K.-i. Yoshida, A. Kawamoto, H. Kurioka, E. Takase, Y. Sasaki, K. Hatanaka, M. Kobayashi, T. Ueyama, T. Hashimoto, et al. Ischemic Preconditioning Upregulates Vascular Endothelial Growth Factor mRNA Expression and Neovascularization via Nuclear Translocation of Protein Kinase C {epsilon} in the Rat Ischemic Myocardium Circ. Res., April 13, 2001; 88(7): 696 - 704. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
